Article info
PDFClinical and epidemiological research
Concise report
Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort
- Correspondence to Dr Carine Salliot, Paris Descartes University, Medicine Faculty UPRES-EA 4058 APHP, Hôpital Cochin, Service de Rhumatologie B, rue du faubourg Saint-Jacques, 75014 Paris, France; carinesalliot{at}cch.aphp.fr
Citation
Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort
Publication history
- Accepted August 17, 2009
- First published September 9, 2009.
Online issue publication
August 10, 2010
Article Versions
- Previous version (9 September 2009).
- Previous version (13 April 2010).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions